BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34155845)

  • 1. Immune Thrombocytopenia Secondary to COVID-19 Infection.
    Kupietzky A; Parnasa E; Fischer M; Kuint R; Daana M
    Isr Med Assoc J; 2021 Jun; 23(6):342-343. PubMed ID: 34155845
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune Thrombocytopenia Following the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine.
    Ganzel C; Ben-Chetrit E
    Isr Med Assoc J; 2021 Jun; 23(6):341. PubMed ID: 34155844
    [No Abstract]   [Full Text] [Related]  

  • 3. Evans syndrome and immune thrombocytopenia in two patients with COVID-19.
    Georgy JT; Jayakaran JAJ; Jacob AS; Gunasekaran K; Korula PJ; Devasia AJ; Iyadurai R
    J Med Virol; 2021 May; 93(5):2642-2644. PubMed ID: 33634495
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute immune thrombocytopaenic purpura in a patient with COVID-19 and decompensated cirrhosis.
    Artru F; Alberio L; Moradpour D; Stalder G
    BMJ Case Rep; 2020 Jul; 13(7):. PubMed ID: 32641442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of IV immunoglobulin in the treatment of vaccine-induced immune thrombotic thrombocytopenia.
    Uzun G; Althaus K; Singh A; Möller P; Ziemann U; Mengel A; Rosenberger P; Guthoff M; Petzold GC; Müller J; Büchsel M; Feil K; Henkes H; Heyne N; Maschke M; Limpach C; Nagel S; Sachs UJ; Fend F; Bakchoul T
    Blood; 2021 Sep; 138(11):992-996. PubMed ID: 34166507
    [No Abstract]   [Full Text] [Related]  

  • 6. Outcomes and management of immune thrombocytopenia secondary to COVID-19: Cleveland clinic experience.
    Kewan T; Gunaratne TN; Mushtaq K; Alayan D; Daw H; Haddad A
    Transfusion; 2021 Jul; 61(7):2014-2018. PubMed ID: 33724474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune thrombocytopenia secondary to COVID-19 infection:  Report of two cases.
    Behlivani E; Tragiannidis A; Hatzipantelis E; Panagopoulou P
    Pediatr Blood Cancer; 2021 Oct; 68(10):e29175. PubMed ID: 34061445
    [No Abstract]   [Full Text] [Related]  

  • 8. Immune Thrombocytopenia.
    Cooper N; Ghanima W
    N Engl J Med; 2019 Sep; 381(10):945-955. PubMed ID: 31483965
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical characteristics, management and outcome of COVID-19-associated immune thrombocytopenia: a French multicentre series.
    Mahévas M; Moulis G; Andres E; Riviere E; Garzaro M; Crickx E; Guillotin V; Malphettes M; Galicier L; Noel N; Darnige L; Terriou L; Guerveno C; Sanchis-Borja M; Moulinet T; Meunier B; Ebbo M; Michel M; Godeau B
    Br J Haematol; 2020 Aug; 190(4):e224-e229. PubMed ID: 32678953
    [No Abstract]   [Full Text] [Related]  

  • 10. Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination.
    Lee EJ; Cines DB; Gernsheimer T; Kessler C; Michel M; Tarantino MD; Semple JW; Arnold DM; Godeau B; Lambert MP; Bussel JB
    Am J Hematol; 2021 May; 96(5):534-537. PubMed ID: 33606296
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation and management of childhood idiopathic (immune) thrombocytopenia.
    Yetman RJ
    J Pediatr Health Care; 2003; 17(5):261-3. PubMed ID: 14576631
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immune thrombocytopenia--pathophysiology and treatment].
    Ghanima W; Holme PA; Tjønnfjord GE
    Tidsskr Nor Laegeforen; 2010 Nov; 130(21):2120-3. PubMed ID: 21052113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune thrombocytopenia and COVID-19: Case report and review of literature.
    Alonso-Beato R; Morales-Ortega A; Fernández FJH; Morón AIP; Ríos-Fernández R; Rubio JLC; Centeno NO
    Lupus; 2021 Aug; 30(9):1515-1521. PubMed ID: 34053365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe immune thrombocytopenia in a critically ill COVID-19 patient.
    Martincic Z; Skopec B; Rener K; Mavric M; Vovko T; Jereb M; Lukic M
    Int J Infect Dis; 2020 Oct; 99():269-271. PubMed ID: 32771636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of anti-SARS-CoV-2 vaccination for patients with immune thrombocytopenia.
    Crickx E; Moulis G; Ebbo M; Terriou L; Briantais A; Languille L; Limal N; Guillet S; Michel M; Mahevas M; Godeau B
    Br J Haematol; 2021 Dec; 195(5):703-705. PubMed ID: 34467525
    [No Abstract]   [Full Text] [Related]  

  • 16. Thrombocytopenia during childhood: what the pediatrician needs to know.
    Buchanan GR
    Pediatr Rev; 2005 Nov; 26(11):401-9. PubMed ID: 16264028
    [No Abstract]   [Full Text] [Related]  

  • 17. Massive Platelet Clumping on Peripheral Blood Smear and Pseudothrombocytopenia in a Patient with COVID-19.
    Can F; Gökçe D; Güney T; Akıncı S; Dilek İ
    Balkan Med J; 2021 May; 38(3):194. PubMed ID: 34142962
    [No Abstract]   [Full Text] [Related]  

  • 18. A single 1 g/kg dose of intravenous immunoglobulin is a safe and effective treatment for immune thrombocytopenia; results of the first HaemSTAR 'Flash-Mob' retrospective study incorporating 961 patients.
    HaemSTAR Collaborators
    Br J Haematol; 2022 Jan; 196(2):433-437. PubMed ID: 34859421
    [No Abstract]   [Full Text] [Related]  

  • 19. Immune thrombocytopenic purpura after COVID-19 infection.
    Levraut M; Ottavi M; Lechtman S; Mondain V; Jeandel PY
    Int J Lab Hematol; 2021 Feb; 43(1):e28-e30. PubMed ID: 32951347
    [No Abstract]   [Full Text] [Related]  

  • 20. A case of symptomatic idiopathic thrombocytopenic purpura during mumps.
    Polat A; Inan M; Cakaloz I; Karakus YT
    Pediatr Hematol Oncol; 2005; 22(3):215-8. PubMed ID: 16020104
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.